Cargando…
Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?
BACKGROUND: A multidisciplinary team meeting (MDM) approach in breast cancer (BC) management is a standard of care. One of the roles of MDMs is to identify the best diagnostic and therapeutic strategies for patients (pts) with new diagnosis of early BC. The purpose of this study was to define whethe...
Autores principales: | Bortot, Lucia, Targato, Giada, Noto, Claudia, Giavarra, Marco, Palmero, Lorenza, Zara, Diego, Bertoli, Elisa, Dri, Arianna, Andreetta, Claudia, Pascoletti, Gaetano, Poletto, Elena, Russo, Stefania, Seriau, Luca, Mansutti, Mauro, Cedolini, Carla, Basile, Debora, Fasola, Gianpiero, Bonotto, Marta, Minisini, Alessandro Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209643/ https://www.ncbi.nlm.nih.gov/pubmed/35747814 http://dx.doi.org/10.3389/fonc.2022.885992 |
Ejemplares similares
-
CDK4/6 Inhibitors as Upfront Treatment in a Patient with Breast Cancer Presenting with a Clinical Critic Situation: A Case Report and Review of the Literature
por: Targato, Giada, et al.
Publicado: (2022) -
1741P Triage procedures for COVID-19 in an Italian cancer centre
por: Targato, G., et al.
Publicado: (2020) -
First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study
por: Basile, Debora, et al.
Publicado: (2021) -
Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID‐19 Pandemic
por: Fasola, Gianpiero, et al.
Publicado: (2021) -
CDK4/6 Inhibitors in Melanoma: A Comprehensive Review
por: Garutti, Mattia, et al.
Publicado: (2021)